{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T09:32:52Z","timestamp":1792315972491,"version":"4.4.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,4,14]],"date-time":"2015-04-14T00:00:00Z","timestamp":1428969600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s00277-015-2358-3","type":"journal-article","created":{"date-parts":[[2015,4,13]],"date-time":"2015-04-13T03:10:47Z","timestamp":1428894647000},"page":"1373-1379","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Factors that influence treatment decision-making in elderly DLBCL patients: a case vignette study"],"prefix":"10.1007","volume":"94","author":[{"given":"M. W. M.","family":"van der Poel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. J.","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. J.","family":"Ossenkoppele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Maartense","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hoogendoorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Wijermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. C.","family":"Schouten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,14]]},"reference":[{"key":"2358_CR1","unstructured":"http:\/\/www.seer.cancer.gov . (Accessed September 19th, 2014)"},{"key":"2358_CR2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","volume":"346","author":"B Coiffier","year":"2002","unstructured":"Coiffier B, Lepage E, Briere J et al (2002) CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346:235\u2013242","journal-title":"N Engl J Med"},{"key":"2358_CR3","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1200\/JCO.2005.09.131","volume":"23","author":"P Feugier","year":"2005","unstructured":"Feugier P, Van Hoof A, Sebban C et al (2005) Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol Off J Am Soc Clin Oncol 23:4117\u20134126","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"2358_CR4","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3109\/10428194.2013.810737","volume":"55","author":"K Boslooper","year":"2014","unstructured":"Boslooper K, Kibbelaar R, Storm H et al (2014) Treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone is beneficial but toxic in very elderly patients with diffuse large B-cell lymphoma: a population-based cohort study on treatment, toxicity and outcome. Leuk Lymphoma 55:526\u2013532","journal-title":"Leuk Lymphoma"},{"key":"2358_CR5","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3109\/10428194.2011.616612","volume":"53","author":"S Hasselblom","year":"2012","unstructured":"Hasselblom S, Stenson M, Werlenius O et al (2012) Improved outcome for very elderly patients with diffuse large B-cell lymphoma in the immunochemotherapy era. Leuk Lymphoma 53:394\u2013399","journal-title":"Leuk Lymphoma"},{"key":"2358_CR6","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2141.2012.09177.x","volume":"158","author":"L Lee","year":"2012","unstructured":"Lee L, Crump M, Khor S et al (2012) Impact of rituximab on treatment outcomes of patients with diffuse large b-cell lymphoma: a population-based analysis. Br J Haematol 158:481\u2013488","journal-title":"Br J Haematol"},{"key":"2358_CR7","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3109\/10428194.2013.790968","volume":"55","author":"C Varga","year":"2014","unstructured":"Varga C, Holcroft C, Kezouh A et al (2014) Comparison of outcomes among patients aged 80 and over and younger patients with diffuse large B-cell lymphoma: a population based study. Leuk Lymphoma 55:533\u2013537","journal-title":"Leuk Lymphoma"},{"key":"2358_CR8","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ejim.2014.05.001","volume":"25","author":"S Diem","year":"2014","unstructured":"Diem S, Ess S, Cerny T, Fruh M, Hitz F (2014) Diffuse large B-cell lymphoma in elderly patients: a retrospective analysis. Eur J Intern Med 25:577\u2013582","journal-title":"Eur J Intern Med"},{"key":"2358_CR9","doi-asserted-by":"crossref","unstructured":"Tien YY, Link BK, Brooks JM, Wright K, Chrischilles E (2014) Treatment of diffuse large B-cell lymphoma in the elderly: regimens without anthracyclines are common and not futile. Leuk Lymphoma","DOI":"10.3109\/10428194.2014.903589"},{"key":"2358_CR10","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1093\/annonc\/mdm563","volume":"19","author":"C Thieblemont","year":"2008","unstructured":"Thieblemont C, Grossoeuvre A, Houot R et al (2008) Non-Hodgkin's lymphoma in very elderly patients over 80\u00a0years. A descriptive analysis of clinical presentation and outcome. Ann Oncol Off J Eur Soc Med Oncol ESMO 19:774\u2013779","journal-title":"Ann Oncol Off J Eur Soc Med Oncol ESMO"},{"key":"2358_CR11","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1093\/annonc\/mdr411","volume":"23","author":"SA Schans van de","year":"2012","unstructured":"van de Schans SA, Wymenga AN, van Spronsen DJ, Schouten HC, Coebergh JW, Janssen-Heijnen ML (2012) Two sides of the medallion: poor treatment tolerance but better survival by standard chemotherapy in elderly patients with advanced-stage diffuse large B-cell lymphoma. Ann Oncol Off J Eur Soc Med Oncol ESMO 23:1280\u20131286","journal-title":"Ann Oncol Off J Eur Soc Med Oncol ESMO"},{"key":"2358_CR12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s002770000255","volume":"80","author":"FP Peters","year":"2001","unstructured":"Peters FP, Lalisang RI, Fickers MM et al (2001) Treatment of elderly patients with intermediate- and high-grade non-Hodgkin's lymphoma: a retrospective population-based study. Ann Hematol 80:155\u2013159","journal-title":"Ann Hematol"},{"key":"2358_CR13","first-page":"165","volume":"72","author":"MW Poel van der","year":"2014","unstructured":"van der Poel MW, Mulder WJ, Ossenkoppele GJ et al (2014) Comorbidity and treatment decision-making in elderly non-Hodgkin's lymphoma patients: a survey among haematologists. Neth J Med 72:165\u2013169","journal-title":"Neth J Med"},{"key":"2358_CR14","unstructured":"http:\/\/www.hovon.nl . (Accessed September 7th 2014)"},{"key":"2358_CR15","unstructured":"http:\/\/www.stz.nl . (Accessed September 7th, 2014)"},{"key":"2358_CR16","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/bjh.12765","volume":"165","author":"A Wieringa","year":"2014","unstructured":"Wieringa A, Boslooper K, Hoogendoorn M et al (2014) Comorbidity is an independent prognostic factor in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOP: a population-based cohort study. Br J Haematol 165:489\u2013496","journal-title":"Br J Haematol"},{"key":"2358_CR17","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.ejca.2005.01.010","volume":"41","author":"DJ Spronsen van","year":"2005","unstructured":"van Spronsen DJ, Janssen-Heijnen ML, Lemmens VE, Peters WG, Coebergh JW (2005) Independent prognostic effect of co-morbidity in lymphoma patients: results of the population-based Eindhoven Cancer Registry. Eur J Cancer 41:1051\u20131057","journal-title":"Eur J Cancer"},{"key":"2358_CR18","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s00277-012-1463-9","volume":"91","author":"TL Lin","year":"2012","unstructured":"Lin TL, Kuo MC, Shih LY et al (2012) The impact of age, Charlson comorbidity index, and performance status on treatment of elderly patients with diffuse large B cell lymphoma. Ann Hematol 91:1383\u20131391","journal-title":"Ann Hematol"},{"key":"2358_CR19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3109\/10428194.2013.788176","volume":"55","author":"F Merli","year":"2014","unstructured":"Merli F, Luminari S, Rossi G et al (2014) Outcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by Comprehensive Geriatric Assessment: results from a study of the Fondazione Italiana Linfomi. Leuk Lymphoma 55:38\u201343","journal-title":"Leuk Lymphoma"},{"key":"2358_CR20","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1365-2141.2005.05508.x","volume":"129","author":"ML Janssen-Heijnen","year":"2005","unstructured":"Janssen-Heijnen ML, van Spronsen DJ, Lemmens VE, Houterman S, Verheij KD, Coebergh JW (2005) A population-based study of severity of comorbidity among patients with non-Hodgkin's lymphoma: prognostic impact independent of International Prognostic Index. Br J Haematol 129:597\u2013606","journal-title":"Br J Haematol"},{"key":"2358_CR21","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00432-010-0973-x","volume":"137","author":"Y Kobayashi","year":"2011","unstructured":"Kobayashi Y, Miura K, Hojo A et al (2011) Charlson Comorbidity Index is an independent prognostic factor among elderly patients with diffuse large B-cell lymphoma. J Cancer Res Clin Oncol 137:1079\u20131084","journal-title":"J Cancer Res Clin Oncol"},{"key":"2358_CR22","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jgo.2013.02.002","volume":"4","author":"TM Wildes","year":"2013","unstructured":"Wildes TM, Ruwe AP, Fournier C et al (2013) Geriatric assessment is associated with completion of chemotherapy, toxicity, and survival in older adults with cancer. J Geriatr Oncol 4:227\u2013234","journal-title":"J Geriatr Oncol"},{"key":"2358_CR23","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1365-2141.2011.08934.x","volume":"156","author":"C Nabhan","year":"2012","unstructured":"Nabhan C, Smith SM, Helenowski I et al (2012) Analysis of very elderly (>\/=80\u00a0years) non-Hodgkin lymphoma: impact of functional status and co-morbidities on outcome. Br J Haematol 156:196\u2013204","journal-title":"Br J Haematol"},{"key":"2358_CR24","doi-asserted-by":"crossref","unstructured":"Oerlemans S, Mols F, Nijziel MR, Zijlstra WP, Coebergh JW, van de Poll-Franse LV (2014) The course of anxiety and depression for patients with Hodgkin's lymphoma or diffuse large B cell lymphoma: a longitudinal study of the PROFILES registry. J Cancer Surviv Res Pract","DOI":"10.1007\/s11764-014-0367-1"},{"key":"2358_CR25","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s11764-013-0286-6","volume":"7","author":"F Mols","year":"2013","unstructured":"Mols F, Husson O, Roukema JA, van de Poll-Franse LV (2013) Depressive symptoms are a risk factor for all-cause mortality: results from a prospective population-based study among 3,080 cancer survivors from the PROFILES registry. J Cancer Surviv Res Pract 7:484\u2013492","journal-title":"J Cancer Surviv Res Pract"},{"key":"2358_CR26","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1245\/s10434-012-2793-5","volume":"20","author":"O Arrieta","year":"2013","unstructured":"Arrieta O, Angulo LP, Nunez-Valencia C et al (2013) Association of depression and anxiety on quality of life, treatment adherence, and prognosis in patients with advanced non-small cell lung cancer. Ann Surg Oncol 20:1941\u20131948","journal-title":"Ann Surg Oncol"},{"key":"2358_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2007.05.001","volume":"64","author":"U Wedding","year":"2007","unstructured":"Wedding U, Kodding D, Pientka L, Steinmetz HT, Schmitz S (2007) Physicians' judgement and comprehensive geriatric assessment (CGA) select different patients as fit for chemotherapy. Crit Rev Oncol Hematol 64:1\u20139","journal-title":"Crit Rev Oncol Hematol"},{"key":"2358_CR28","doi-asserted-by":"crossref","first-page":"4547","DOI":"10.1002\/cncr.24490","volume":"115","author":"A Tucci","year":"2009","unstructured":"Tucci A, Ferrari S, Bottelli C, Borlenghi E, Drera M, Rossi G (2009) A comprehensive geriatric assessment is more effective than clinical judgment to identify elderly diffuse large cell lymphoma patients who benefit from aggressive therapy. Cancer 115:4547\u20134553","journal-title":"Cancer"},{"key":"2358_CR29","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1200\/JCO.20.2.494","volume":"20","author":"L Repetto","year":"2002","unstructured":"Repetto L, Fratino L, Audisio RA et al (2002) Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol Off J Am Soc Clin Oncol 20:494\u2013502","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"2358_CR30","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/COC.0b013e318210f9ce","volume":"35","author":"AM Horgan","year":"2012","unstructured":"Horgan AM, Leighl NB, Coate L et al (2012) Impact and feasibility of a comprehensive geriatric assessment in the oncology setting: a pilot study. Am J Clin Oncol 35:322\u2013328","journal-title":"Am J Clin Oncol"},{"key":"2358_CR31","first-page":"1","volume":"23","author":"AA Aaldriks","year":"2014","unstructured":"Aaldriks AA, Giltay EJ, Nortier JW et al (2014) Prognostic significance of geriatric assessment in combination with laboratory parameters in elderly patients with aggressive non-Hodgkin Lymphoma. Leuk Lymphoma 23:1\u201329","journal-title":"Leuk Lymphoma"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-015-2358-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-015-2358-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-015-2358-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T09:58:54Z","timestamp":1566554334000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-015-2358-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,14]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["2358"],"URL":"https:\/\/doi.org\/10.1007\/s00277-015-2358-3","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,14]]}}}